This is the worst-listing day performance for IPOs listed this calendar year. The poor listing performance comes despite encouraging response to the Hyderabad-based firm’s Rs 1,300-crore IPO. The offering was oversubscribed 12 times. Market players blamed poor secondary market conditions for the weak debut.
At the last close, the company had a market cap of 4,569 crore. Rainbow Medicare trades at a price-to-earnings (P/E) ratio of around 36 times based on trailing 12-month (Dec 21) earnings for share (EPS) of Rs 12.6.
Peers such as Apollo Hospital and Fortis Healthcare are trading at P/E of 75 times and 55 times, said an analyst.
Rainbow Medicare is a leading pediatric multi-specialty healthcare chain with strong clinical expertise in managing complex diseases.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)